Zobrazeno 1 - 10
of 28
pro vyhledávání: '"J. E. Carlsen"'
Autor:
T. Honkanen, C. Höglund, O. H. Soerensen, T. Pellinen, A. Leth, M. Buchmann, N. Maltbæk, J. E. Carlsen
Publikováno v:
Clinical Drug Investigation. 10:221-227
The 24-hour effect of cilazapril monotherapy on blood pressure was evaluated in a controlled, double-blind, randomised, dose-response trial carried out in 6 Scandinavian centres. After 4 weeks of single-blind placebo administration, male and female o
Publikováno v:
SP-192: 2000 Canmet/ACI Conference on Durability of Concrete.
A model for predicting the initiation period of reinforcement corrosion for marine concrete structures was presented at the CANMET/ACI International Conference on Durability, Sydney, Australia, 1997. The theory has been refined to be valid also for s
Publikováno v:
SP-170: Fourth CANMET/ACI International Conference on Durability of Concrete.
Publikováno v:
ACI Materials Journal. 93
Deterioration of reinforced concrete structures due to chloride ingress followed by reinforcement corrosion is a serious problem all over the world. Service life predictions, both for existing and planned structures, are therefore of great importance
Autor:
L, Køber, C, Torp-Pedersen, J E, Carlsen, H, Bagger, P, Eliasen, K, Lyngborg, J, Videbaek, D S, Cole, L, Auclert, N C, Pauly
Publikováno v:
The New England journal of medicine. 333(25)
Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces mortality among survivors of acute myocardial infarction, but whether to use ACE inhibitors in all patients or only in selected patients is uncertain.We screened 6676 consecutive p
Publikováno v:
"SP-145: Durability of Concrete -- Proceedings Third CANMET - ACI International Conference, Nice, France 1994".
Autor:
M. Preti, Kenneth Dickstein, H. Ohlin, J. E. Carlsen, Jjv McMurray, T. Haghfelt, Christian Torp-Pedersen, O. Gotzsche, L. Køber, D. Dacoronias
Publikováno v:
European Journal of Heart Failure Supplements. 4:89-89
Publikováno v:
The American Journal of Medicine. 87:S79-S82
This open uncontrolled trial was undertaken to evaluate the safety and the efficacy of a new angiotensin-converting enzyme inhibitor cilazapril in patients with both hypertension and renal impairment defined as endogenous creatinine clearance below 5
Publikováno v:
Clinical Physiology. 1:375-384
The purpose of this study was to evaluate the immediate central and peripheral haemodynamic effects of a new vasodilating agent P 1134, in hypertensive man. After oral administration of 25 mg P 1134, the maximal haemodynamic changes were (mean +/- 1
Publikováno v:
Clinical Physiology. 1:45-48